Clinical Trial: FG001 Near-Infrared Fluorescence Imaging During Tumor Resection in Newly Diagnosed High-Grade Glioma

U.S., May 28 -- ClinicalTrials.gov registry received information related to the study (NCT07609472) titled 'FG001 Near-Infrared Fluorescence Imaging During Tumor Resection in Newly Diagnosed High-Grade Glioma' on May 12.

Brief Summary: This clinical trial aims to determine if FG001 can assist surgeons in identifying the difference between tumor and healthy tissue during surgery in participants with newly diagnosed high-grade glioma. The scheduled neurosurgical tumor resection will occur under NIR fluorescence guidance and support the surgeons in achieving complete removal of the cancer.

FG001 is a 'fluorescent imaging agent,' which is a dye that glows under a special light to help doctors see certain tissues.

The main questions it aims t...